Ivermectin, an anti-parasitic drug often used in animals, has seen a steep rise in prescriptions as patients seek out alternative treatments for COVID-19. If a patient insists on this drug, infectious ...

It is dangerous to market Ivermectin as a treatment against COVID-19 as the drug has not been properly tested for humans All clinical trials on the drug are being closely monitored. The Access to ...

Ivermectin is effective against other parasites, but in a noncontrolled study, a single standard dose eradicated head lice in only 23% of subjects. Examining efficacy and safety, Chosidow and ...

Interest in human use of ivermectin grew when people began taking it to prevent or treat COVID-19, despite the FDA and other ...

Background The broad-spectrum antiparasitic drug ivermectin is widely used in children, and its use in children weighing < 15 kg is off-label, as little data is available to inform the use of ...

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19. In ...

U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their ...

Alarge study investigating potential repurposed treatments for COVID-19 has found no benefit for ivermectin in reducing a person’s risk of being hospitalized or dying from the disease, according to a ...

After FDA-authorized COVID-19 medications (e.g., Paxlovid) became available, ivermectin and hydroxychloroquine use dropped by 93% in outpatient settings from March 1, 2022 to June 30, 2023.

Fenbendazole and ivermectin are two of those drugs that have been found effective. There is probably never going to be one ...